Assessment of peripheral neuropathy using measurement of the current perception threshold with the Neurometer® in patients with type 2 diabetes mellitus

Journal of International Medical Research

Volumn 33, Issue 4, 2005, Pages 442-453

  Matsutomo, Rika ^a   Takebayashi, K ^a   Aso, Y ^a  

^a DOKKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Current perception threshold; Diabetic neuropathy; Nerve conduction velocity; Neurometer ; Type 2 diabetes

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR NERVE CONDUCTION; MYELINATED NERVE; NERVE FUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCEPTIVE THRESHOLD; SENSORY NERVE CONDUCTION; SYSTOLIC BLOOD PRESSURE; VIBRATION SENSE;

EID: 23044438043     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000503300410     Document Type: Article

References (34)

1. Ward JD, Barnes CG, Fisher DJ, Jessop JD: Improvement in nerve conduction following treatment in newly diagnosed diabetics. Lancet 1971; 1: 428-431.
2. Young MJ, Breddy JL, Veves A, Boulton AJM: The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. Diabetes Care 1994; 17: 557-560.
3. Wheeler T, Watkins PJ: Cardiac denervation in diabetes. Br Med J 1973; 4: 584-586.
4. Hilsted J, Parving HH, Christensen NJ, Benn J, Galbo H: Hemodynamics in diabetic orthostatic hypotension. J Clin Invest 1981; 68: 1427-1434.
5. Abad F, Diaz-Gomez NM, Rodriguez I, Perez R, Delgado JA: Subclinical pain and thermal sensory dysfunction in children and adolescents with Type 1 diabetes mellitus. Diabet Med 2002; 19: 827-831.
6. Sosenko JM, Kato M, Soto R, Bild DE: Comparison of quantitative sensory-threshold measures for their association with foot ulceration in diabetic patients. Diabetes Care 1990; 13: 1057-1061.
7. Perkins BA, Bril V: Diabetic neuropathy: a review emphasizing diagnostic methods. Clin Neurophysiol 2003; 114: 1167-1175.
8. Bleecker ML: Quantifying sensory loss in peripheral neuropathies. Neurobehav Toxicol Teratol 1985; 7: 305-308.
9. Rendell MS, Dovgan DJ, Bergman TF, O'Donnell GP, Drobny EP, Katims JJ: Mapping diabetic sensory neuropathy by current perception threshold testing. Diabetes Care 1989; 12: 636-640.
10. Wallace MS, Dyck JB, Rossi SS, Yaksh TL: Computer-controlled lidocaine infusion for the evaluation of neuropathic pain after peripheral nerve injury. Pain 1996; 66: 69-77.
11. Katims JJ, Mitsuhata H, Miyazaki T: Electrodiagnostic evaluation of sensory nerve function in the patient with pain: neuroselective current perception threshold (CPT) and pain tolerance threshold (PTT) (in Japanese). Pain Clinic 1998; 19: 535-549.
12. Katims JJ, Rouvelas P, Sadler BT, Weseley SA: Current perception threshold. Reproducibility and comparison with nerve conduction in evaluation of carpal tunnel syndrome. ASAIO Trans 1989; 35: 280-284.
13. Liu S, Kopacz DJ, Carpenter RL: Quantitative assessment of differential sensory nerve block after lidocaine spinal anesthesia. Anesthesiology 1995; 82: 60-63.
14. Riley ET, Hamilton CL, Cohen SE: Intrathecal sufentanil produces sensory changes without hypotension in male volunteers. Anesthesiology 1998; 89: 73-78.
15. Takekuma K, Ando F, Niino N, Shimokata H: Prevalence of hyperesthesia detected by current perception threshold test in subjects with glucose metabolic impairments in a community. Intern Med 2002; 41: 1124-1129.
16. Davis MD: Diabetic retinopathy. A clinical overview. Diabetes Care 1992; 15: 1844-1874.
17. Frykberg RG, Lavery LA, Pham H, Harvey C, Harkless L, Veves A: Role of neuropathy and high foot pressures in diabetic foot ulceration. Diabetes Care 1998; 21: 1714-1719.
18. Hodge AM, Dowse GK, Zimmet PZ, Gareeboo H, Westerman RA, Tuomilehto J, et al: Factors associated with impaired vibration perception in Mauritians with normal and abnormal glucose tolerance. Mauritius NCD Study Group. J Diabetes Complications 1995; 9: 149-157.
19. Donaghue VM, Giurini JM, Rosenblum BI, Weissman PN, Veves A: Variability in function measurements of three sensory foot nerves in neuropathic diabetic patients. Diabetes Res Clin Pract 1995; 29: 37-42.
20. Katims JJ, Long DM, Ng LK: Transcutaneous nerve stimulation. Frequency and waveform specificity in humans. Appl Neurophysiol 1986; 49: 86-91.
21. Masson EA, Boulton AJ: The Neurometer: validation and comparison with conventional tests for diabetic neuropathy. Diabet Med 1991; 8 Spec No: S63-S66.
22. Prendergast JJ, Miranda G, Sanchez M: Improvement of sensory impairment in patients with peripheral neuropathy. Endocr Pract 2004; 10: 24-30.
23. Lee Y, Robinson M, Wong N, Chan E, Charles MA: The effect of pentoxifylline on current perception thresholds in patients with diabetic sensory neuropathy. J Diabetes Complications 1997; 11: 274-278.
24. Ionescu-Tirgoviste C, Pruna S, Bajenaru O, Cheta D, Mincu I: The perception threshold to an electric stimulus deeply applied in the lower limbs in normal and diabetic subjects. Diabetes Res Clin Pract 1987; 3: 249-256.
25. Masson EA, Veves A, Fernando D, Boulton AJ: Current perception thresholds: a new, quick, and reproducible method for the assessment of peripheral neuropathy in diabetes mellitus. Diabetologia 1989; 32: 724-728.
26. Chu NS: Current perception thresholds in toe-to-digit transplantation and digit-to-digit replantation. Muscle Nerve 1996; 19: 183-186.
27. Rendell MS, Katims JJ, Richter R, Rowland F: A comparison of nerve conduction velocities and current perception thresholds as correlates of clinical severity of diabetic sensory neuropathy. J Neurol Neurosurg Psychiatry 1989; 52: 502-511.
28. Veves A, Young MJ, Manes C, Boulton AJ: Differences in peripheral and autonomic nerve function measurements in painful and painless neuropathy. A clinical study. Diabetes Care 1994; 17: 1200-1202.
29. Pitei DL, Watkins PJ, Stevens MJ, Edmonds ME: The value of the Neurometer in assessing diabetic neuropathy by measurement of the current perception threshold. Diabet Med 1994; 11: 872-876.
30. Suzuki KI, Chung Y, Kobayashi Y, Goto Y: Current perception thresholds: a new method for the assessment of peripheral sensory neuropathy in diabetes mellitus (in Japanese; English abstract). Peripheral Nerve (Japan) 1995; 6: 159-163.
31. Kempler P, Kadar E, Marton A, Vargha P, Hermanyi Z, Keresztes K: Sensory nerve dysfunction in NIDDM and in newly diagnosed NIDDM detected by the Neurometer®: relation to autonomic function. In: Diabetic Neuropathy: New Concepts and Insights (Hotta N, Greene DA, Ward JD, Sima AAF, Boulton AJM, eds). Dublin: Elsevier Science, 1995; pp291-296.
32. Greene DA, Lattimer SA, Sima AAF: Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 1987; 316: 599-606.
33. Adler AI, Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Smith DG: Risk factors for diabetic peripheral sensory neuropathy. Results of the Seattle Prospective Diabetic Foot Study. Diabetes Care 1997; 20: 1162-1167.
34. Kalter-Leibovici O, Yosipovitch G, Gobbay U, Yarnitsky D, Karp M: Factor analysis of thermal and vibration thresholds in young patients with Type 1 diabetes mellitus. Diabet Med 2001; 18: 213-217.